Apollomics, Inc. (NASDAQ:APLMW) Short Interest Update

Apollomics, Inc. (NASDAQ:APLMW) saw a significant drop in short interest in December. As of December 31st, there was short interest totalling 700 shares, a drop of 99.0% from the December 15th total of 68,200 shares. Based on an average daily volume of 82,000 shares, the days-to-cover ratio is currently 0.0 days.

Apollomics Stock Performance

Shares of APLMW stock traded down $0.00 during trading on Wednesday, hitting $0.01. The company’s stock had a trading volume of 100 shares, compared to its average volume of 21,556. The business has a fifty day moving average of $0.01 and a 200-day moving average of $0.01. Apollomics has a 52 week low of $0.01 and a 52 week high of $0.04.

Apollomics Company Profile

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.